Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas

ORL J Otorhinolaryngol Relat Spec. 2012;74(1):33-7. doi: 10.1159/000334968. Epub 2012 Jan 13.

Abstract

Background: Vestibular schwannomas (VS) are benign tumors of the nervous system that are usually sporadic but also occur in the inherited disorder neurofibromatosis type 2 (NF2). In VS, losses of chromosomal material and mutations of the NF2 gene have been established to be causative. For a subset of VS without detectable gene alterations, promoter inactivation by hypermethylation has been suggested. However, published data are very limited and contradictory.

Methods: We analyzed NF2 gene promoter methylation in 35 sporadic VS by methylation-specific PCR.

Results: Twenty-three of the tumors were informative, showing no promoter methylation. In the remaining 12 tumors, promoter methylation could neither be verified nor excluded.

Conclusions: Our study suggests that NF2 gene inactivation by promoter hypermethylation is a rare or very uncommon mechanism of NF2 gene inactivation in sporadic VS. Other mechanisms destabilizing the NF2 gene product, yet to be identified, might play a role in the genesis of VS apart from the loss or mutation of the NF2 gene.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • DNA Methylation
  • DNA, Neoplasm / genetics*
  • DNA, Neoplasm / metabolism
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Neurofibromin 2 / genetics*
  • Neurofibromin 2 / metabolism
  • Neuroma, Acoustic / genetics*
  • Neuroma, Acoustic / metabolism
  • Neuroma, Acoustic / pathology
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Young Adult

Substances

  • DNA, Neoplasm
  • Neurofibromin 2